Trastuzumab plus paclitaxel in HER-2 positive metastatic breast cancer: A single institutional experience

被引：0
|
作者：
Capobianco, A. M. L. [1 ]
Di Leo, P. [1 ]
Bochicchio, A. M. [1 ]
Coccaro, M. [1 ]
Romano, G. [1 ]
Tartarone, A. [1 ]
Ardito, R. [1 ]
Musto, C. [1 ]
Barone, M. [1 ]
Guarigli, R. [1 ]
Di Renzo, N. [1 ]
机构：
[1] Reg Hosp, Ctr Riferimento Oncol Basilicata, Div Hematol Oncol, Rionero In Vulture, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141 / 142
页数：2
相关论文
共 50 条
  • [41] An Open-Label Safety Study of Lapatinib Plus Trastuzumab Plus Paclitaxel in First-Line HER2-Positive Metastatic Breast Cancer
    Esteva, Francisco J.
    Franco, Sandra X.
    Hagan, Maura K.
    Brewster, Abenaa M.
    Somer, Robert A.
    Williams, Will
    Florance, Allison M.
    Turner, Simon
    Stein, Steven
    Perez, Alejandra
    ONCOLOGIST, 2013, 18 (06): : 661 - 666
  • [42] Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer
    Gonzalez-Angulo, Ana M.
    Hortobagyi, Gabriel N.
    Esteva, Francisco J.
    ONCOLOGIST, 2006, 11 (08): : 857 - 867
  • [43] Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer
    Ozyukseler, Deniz Tataroglu
    Basak, Mustafa
    Ay, Seval
    Koseoglu, Aygul
    Arici, Serdar
    Oyman, Abdilkerim
    Surmeli, Heves
    Turan, Merve
    Turan, Nedim
    Odabas, Hatice
    Yildirim, Mahmut E.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 547 - 554
  • [44] EVALUATION OF THE PREDICTIVE SIGNIFICANCE OF SERUM HER-2/NEU, CA15-3 AND EGFR IN HER-2/NEU POSITIVE METASTATIC BREAST CANCER IN A PHASE IIB STUDY: PACLITAXEL (PCT) VERSUS PCT plus TRASTUZUMAB (T)
    Zancan, Matelda
    Rocco, Stefano
    Morabito, Alessandro
    Meo, Sabrina
    Crivellari, Diana
    Filippelli, Gianfranco
    Silingardi, Vittorio
    De Sio, Livia
    Papaldo, Paola
    Carillio, Guido
    Sarmiento, Roberta
    Spada, Antonella
    Veronesi, A.
    Caputo, Antonio
    Amadori, Dino
    Cognetti, Francesco
    Gion, Massimo
    Gasparini, Giampietro
    ANNALS OF ONCOLOGY, 2004, 15 : 26 - 27
  • [45] Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer
    Sara Tolaney
    Howard Burris
    Elaina Gartner
    Ingrid A. Mayer
    Cristina Saura
    Matthew Maurer
    Eva Ciruelos
    Agustin A. Garcia
    Frank Campana
    Bin Wu
    Yi Xu
    Jason Jiang
    Eric Winer
    Ian Krop
    Breast Cancer Research and Treatment, 2015, 149 : 151 - 161
  • [46] Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer
    Tolaney, Sara
    Burris, Howard
    Gartner, Elaina
    Mayer, Ingrid A.
    Saura, Cristina
    Maurer, Matthew
    Ciruelos, Eva
    Garcia, Agustin A.
    Campana, Frank
    Wu, Bin
    Xu, Yi
    Jiang, Jason
    Winer, Eric
    Krop, Ian
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 149 (01) : 151 - 161
  • [47] Pyrotinib plus trastuzumab versus pertuzumab plus trastuzumab in patients with HER2-positive metastatic breast cancer: A multicenter, retrospective study
    Wang, B.
    You, S.
    Xie, Y.
    Xu, F.
    Sang, D.
    Luo, T.
    Yuan, P.
    ANNALS OF ONCOLOGY, 2023, 34 : S361 - S362
  • [48] Brain metastases in breast cancer patients overexpressing HER-2 and treated with trastuzumab: A single institution experience
    Quercia, S.
    Bernardi, A.
    Rosati, M.
    Cacciari, N.
    Massari, F.
    Sperandi, F.
    Zamagni, C.
    Martoni, A.
    ANNALS OF ONCOLOGY, 2006, 17 : XI9 - XI9
  • [49] EXPANDED EXPERIENCE WITH INTRAVENOUS OR ORAL VINORELBINE (VNR) PLUS TRASTUZUMAB (T) IN CHEMONAIVE PATIENTS WITH HER-2 OVEREXPRESSING METASTATIC BREAST CANCER (MBC)
    Bernardo, A.
    Palumbo, R.
    Villani, G.
    Strada, M. R.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 27 - 27
  • [50] Low-dose doxorubicin combined with trastuzumab in HER2-positive metastatic breast cancer: A single institution experience
    Lohman, Elise de Savornin
    Linn, Sabine C.
    Kok, Marleen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345